Merck Inc. signs License agreement with Desert Scientific Software For Proasis2protein structure database and visualisation system

DesertSci is pleased to announce the licensing of their flagship product, Proasis2 protein structure database and visualisation system, by one of the world’s leading pharmaceutical companies, Merck & Co., Inc., NJ, USA.

Proasis2 is the industry’s leading protein structure database and visualization system, and will be used throughout Merck’s medicines research organization to enhance the efficiency of their drug discovery programs.

Proasis2 is a web-based tool designed specifically for drug discovery research. The software allows users to make complex, high quality decisions on Discovery projects by using more complete sets of in-house and public domain structural information and leveraging advanced scientific tools, behind an easy-to-use interface.

Click here to learn more about Proasis2